Primary Site >> Liver Cancer

Gene >> HDAC9

Journal: Mol Genet Genomics. 2010 Apr;283(4):341-9.
Title: High-throughput assessment of CpG site methylation for distinguishing between HCV-cirrhosis and HCV-associated hepatocellular carcinoma.
Author: Archer, Kellie J|Mas, Valeria R|Maluf, Daniel G|Fisher, Robert A
PMID: 20165882
Journal: Clin Chem Lab Med. 2010 Dec;48(12):1785-91.
Title: Combination of polymorphisms within the HDAC1 and HDAC3 gene predict tumor recurrence in hepatocellular carcinoma patients that have undergone transplant therapy.
Author: Yang, Zhe|Zhou, Lin|Wu, Li-Ming|Xie, Hai-Yang|Zhang, Feng|Zheng, Shu-Sen
PMID: 20731616
Journal: PLoS One. 2010 Dec 29;5(12):e14460.
Title: Identification of histone deacetylase 3 as a biomarker for tumor recurrence following liver transplantation in HBV-associated hepatocellular carcinoma.
Author: Wu, Li-Ming|Yang, Zhe|Zhou, Lin|Zhang, Feng|Xie, Hai-Yang|Feng, Xiao-Wen|Wu, Jian|Zheng, Shu-Sen
PMID: 21206745
Journal: J Hepatol. 2014 Apr;60(4):792-801.
Title: Sulfatide epigenetically regulates miR-223 and promotes the migration of human hepatocellular carcinoma cells.
Author: Dong, Yi Wei|Wang, Rong|Cai, Qian Qian|Qi, Bing|Wu, Wei|Zhang, Yong Hu|Wu, Xing Zhong
PMID: 24333181
Journal: PLoS One. 2014 Aug 28;9(8):e106224.
Title: The histone deacetylase inhibitor, Vorinostat, represses hypoxia inducible factor 1 alpha expression through translational inhibition.
Author: Hutt, Darren M|Roth, Daniela Martino|Vignaud, Helene|Cullin, Christophe|Bouchecareilh, Marion
PMID: 25166596
Journal: Cell Physiol Biochem. 2015;35(2):729-39.
Title: MiR-376a and histone deacetylation 9 form a regulatory circuitry in hepatocellular carcinoma.
Author: Zheng, Yongxia|Chen, Huan|Yin, Manxiang|Ye, Xiaoqian|Chen, Guiqian|Zhou, Xinmei|Yin, Lei|Zhang, Chengwen|Ding, Baoyue
PMID: 25613642
Journal: J Korean Med Sci. 2015 Oct;30(10):1375-80.
Title: Histone Deacetylases and Their Regulatory MicroRNAs in Hepatocarcinogenesis.
Author: Kim, Hyung Seok|Shen, Qingyu|Nam, Suk Woo
PMID: 26425032